Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q3 EPS Loss of $0.10
Go back to Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q3 EPS Loss of $0.10| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 23.36 +0.76 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.60 | 52 Week High | $42.49 | |||
| Open | $22.67 | 52 Week Low | $16.64 | |||
| Day High | $23.79 | P/E | N/A | |||
| Day Low | $22.67 | EPS | $-0.42 | |||
| Volume | 1,495,872 | |||||
